|
Prev
Next
|
|
| As on Jun 27, 2017 12:00 AM |
Your results on : Hot Pursuit |
|
|
| The announcement was made on Monday, 26 June 2017. The market was shut on Monday, 26 June 2017, on account of holiday. Meanwhile, the S&P BSE Sensex was down 69.45 points, or 0.22% to 31,072.69. On the BSE, 34,702 shares were traded in the counter so far, compared with average daily volumes of 1.54 lakh shares in the past one quarter. The stock had hit a high of Rs 535.35 and a low of Rs 527.45 so far during the day. The stock had hit a record high of Rs 558 on 12 June 2017. The stock had hit a 52-week low of Rs 305.05 on 24 June 2016. The stock had outperformed the market over the past one month till 23 June 2017, gaining 19.03% compared with 2.55% rise in the Sensex. The scrip had also outperformed the market in past one quarter, gaining 17.5% as against Sensex's 6.16% gains. The scrip had also outperformed the market in past one year, jumping 66.83% as against Sensex's 15.32% gains. The large-cap company has equity capital of Rs 102.37 crore. Face value per share is Re 1. Cadila Healthcare said that its board approved in-principle to raise funds by issue of equity shares/ convertible bonds/debentures through qualified institutional placement (QIP)/ global depository receipts (GDR)/American depository receipts (ADR), for an aggregate amount up to Rs 10000 crore. The board also approved to issue secured/unsecured redeemable non-convertible debentures/foreign currency bonds on private placement basis for an amount up to Rs 3500 crore in the financial year 2017—2018. Further, the board also approved to issue foreign currency bond/foreign currency convertible bonds for an amount up to Rs 5000. Separately, Cadila Healthcare announced that it has received final approval from the United States Food & Drug Administration (USFDA) to market Entecavir Tablets in the strengths of 0.5 mg and 1 mg. The announcement was made during market hours today, 27 June 2017. The drug is used in the treatment of Hepatitis B virus infection and will be produced at the group's formulations manufacturing facility at the Pharma special economic zone (SEZ) in Ahmedabad. The estimated sale of Entecavir Tablets in US is $166.3 million as per the IMS MAT April 2017. Cadila Healthcare's consolidated net profit fell 32.2% to Rs 385.5 crore on 6.5% rise in net sales to Rs 2417.50 crore in Q4 March 2017 over Q4 March 2016. Cadila Healthcare is an innovative, global pharmaceutical company that discovers, develops, manufactures and markets a broad range of healthcare therapies.
|
Meanwhile, the S&P BSE Sensex was up 75.42 points, or 0.24% at 31,213.63. On the BSE, 40,000 shares were traded on the counter so far as against the average daily volumes of 4.79 lakh shares in the past one quarter. The stock had hit a high of Rs 246 and a low of Rs 241.30 so far during the day. The stock had hit a record high of Rs 266.40 on 13 June 2017 and a 52-week low of Rs 139.35 on 24 June 2016. The stock had outperformed the market over the past one month till 23 June 2017, advancing 7.11% compared with the Sensex's 2.55% rise. The scrip had also outperformed the market over the past one quarter advancing 19.61% as against the Sensex's 6.16% rise. The scrip had also outperformed the market over the past one year advancing 65.88% as against the Sensex's 15.32% rise. The large-cap company has equity capital of Rs 50.90 crore. Face value per share is Rs 1. Before turning ex-dividend, the stock offered a dividend yield of 1.21% based on the closing price of Rs 247 on Friday, 23 June 2017. Apollo Tyres' consolidated net profit fell 16.1% to Rs 228.24 crore on 10.2% increase in net sales to Rs 3269.22 crore in Q4 March 2017 over Q4 March 2016. Apollo Tyres is an international tyre major with manufacturing units in India, the Netherlands and Hungary. The company markets its products under its two global brands - Apollo and Vredestein. The company's products are available in over 100 countries through a network of branded, exclusive and multi-product outlets.
|
| The announcement was made on Monday, 26 June 2017, when the stock markets were closed for local holiday. Meanwhile, the S&P BSE Sensex was up 98.39 points, or 0.32%, to 31,236.60. The S&P BSE Mid-Cap index was down 26.72 points, or 0.18%, to 14,557.09. On the BSE, so far 3,076 shares were traded in the counter, compared with average daily volumes of 1.24 lakh shares in the past one quarter. The stock had hit a high of Rs 1,048.05 and low of Rs 1,039.45 so far during the day. The stock had hit a record high of Rs 1447.55 on 22 February 2017. The stock hit a 52-week low of Rs 431.35 on 8 April 2016. The mid-cap company has equity capital of Rs 54.28 crore. Face value per share is Rs 10. On a consolidated basis, net profit of Infibeam Incorporation rose 468.49% to Rs 13.53 crore on 61.22% rise in net sales to Rs 120.51 crore in Q4 March 2017 over Q4 March 2016. Infibeam Incorporation is an e-commerce company, focused on developing successful e-commerce platforms and ecosystems.
|
| The announcement was made on Sunday, 25 June 2017. Stock markets remained closed on Monday, 26 June 2017, for a local holiday. Meanwhile, the S&P BSE Sensex was up 127.68 points, or 0.41%, to 31,265.89. The S&P Small-Cap index was up 42.67 points, or 0.28%, to 15,424.57. On BSE, so far 12,000 shares were traded in the counter, compared with average daily volume of 1.53 lakh shares in the past one quarter. The stock hit a high of Rs 66.60 and a low of Rs 65.70 so far during the day. The stock hit a record high of Rs 84.70 on 23 May 2017. The stock hit a 52-week low of Rs 21.11 on 9 November 2016. The small-cap company has equity capital of Rs 26.67 crore. Face value per share is Re 1. LT Foods said that the company is inaugurating rice plant at Rotterdam, Netherlands in Europe with an initial processing capacity of 60,000 tonne on 28 June 2017. The company would be manufacturing a wide range of rice including popular varieties like Basmati, Thai, Jasmine and American rice from the new plant. On consolidated basis, LT Foods' net profit rose 507.75% to Rs 33.73 crore on 19.5% growth in net sales to Rs 962.15 crore in Q4 March 2017 over Q4 March 2016. LT Foods has a diversified product portfolio of branded basmati rice, value-added staples and organic food.
|
Meanwhile, the S&P BSE Sensex was down 147.79 points or 0.47% at 31,142.95. The S&P BSE Small-Cap index fell 228.46 points or 1.46% at 15,381.03. On the BSE, 3.53 lakh shares were traded on the counter so far as against the average daily volumes of 5.07 lakh shares in the past two weeks. The stock had hit a high of Rs 19.45 and a low of Rs 18.45 so far during the day. The stock had hit a 52-week high of Rs 28.30 on 15 September 2016 and a record low of Rs 16.90 on 9 November 2016. Shares of Punj Lloyd had risen 8.7% in the preceding two trading sessions to settle at Rs 19.35 yesterday, 22 June 2017, from its close of Rs 17.80 on 20 June 2017. Punj Lloyd reported net loss of Rs 181.58 crore in Q4 March 2017, lower than net loss of Rs 396.15 crore in Q4 March 2016. Net sales rose 29.3% to Rs 889.98 crore in Q4 March 2017 over Q4 March 2016. The Punj Lloyd Group is a diversified international conglomerate offering EPC services in energy and infrastructure along with engineering and manufacturing capabilities in the defence sector.
|
| Meanwhile, the S&P BSE Sensex was down 116.10 points, or 0.37% to 31,174.64. On the BSE, 4.27 lakh shares were traded in the counter so far, compared with average daily volumes of 3.87 lakh shares in the past one quarter. The stock had hit a high of Rs 509.20 and a low of Rs 486.60 so far during the day. The stock had hit a 52-week high of Rs 635.35 on 9 September 2016. The stock had hit a 52-week low of Rs 426.45 on 9 November 2016. The stock had underperformed the market over the past one month till 22 June 2017, falling 11.17% compared with Sensex's 2.35% gains. The scrip had also underperformed the market in past one quarter, dropping 12.02% as against Sensex's 7.28% rise. The scrip had also underperformed the market in past one year, dropping 8.78% as against Sensex's 16.91% rise. The large-cap company has equity capital of Rs 262.99 crore. Face value per share is Rs 10. The spinoff will take care of its interests in railway, metro, airport and road projects even as the proposed listing of Infrastructure Investment Trust (InvIT) faces what the company calls “some procedural delays” after receiving the nod from the stock market regulator, report added. Meanwhile, Reliance Infrastructure said after market hours yesterday, 22 June 2017 that Reliance Defence, a fully owned subsidiary of Reliance Infrastructure, signed a memorandum of understanding (MOU) at the Paris Air Show with Daher Aerospace, France, a leading supplier of integrated systems for Aerospace and Advanced Technologies. Daher Aerospace is tier one manufacturer in Aerostructures segment comprising fuselage sections and fairings made of composites as well as conventional metals for Dassault Aviation and other leading global aircraft manufacturers. Signing this MOU on the sidelines of the Paris Air Show, Reliance Defence envisages a strategic partnership with Daher with aim to jointly explore opportunities in design and manufacture of composite parts; design and build welded ducts, metal conduits, swaged pipes and cable harness supports; aerostructure components, integrated logistics, airframes/assemblies and related industrial activities. On a consolidated basis, Reliance Infrastructure reported net profit of Rs 40.94 crore in Q4 March 2017 as against net loss of Rs 327.42 crore in Q4 March 2016. Net sales declined 10.3% to Rs 4992.55 crore in Q4 March 2017 over Q4 March 2016. Reliance Infrastructure (RInfra) is one of the largest infrastructure companies, developing projects through various special purpose vehicles (SPVs) in several high growth sectors such as power, roads and metro rail in the infrastructure space and the defence sector.
|
Meanwhile, the S&P BSE Sensex was down 116.10 points, or 0.37% at 31,174.64. The S&P BSE Small-Cap index was down 206.75 points, or 1.32% at 15,402.74. On the BSE, 8,311 shares were traded on the counter so far as against the average daily volumes of 5,841 shares in the past two weeks. The stock had hit a high of Rs 440.10 so far during the day, which is also its record high. The stock hit a low of Rs 414.70 so far during the day. The stock had hit a 52-week low of Rs 282 on 27 December 2016. Shares of Apcotex Industries had rallied 14.58% in the preceding five trading sessions to settle at Rs 427.65 yesterday, 22 June 2017, from its close of Rs 373.25 on 16 June 2017. Apcotex Industries' net profit fell 58.8% to Rs 3.53 crore on 28.2% increase in net sales to Rs 86.73 crore in Q4 March 2017 over Q4 March 2016. Apcotex Industries is one of the leading producers of performance emulsion polymers in India. Its product range includes VP latex, carboxylated and non-carboxylated SB latexes, acrylic latexes, nitrile latex and synthetic rubber.
|
| The announcement was made after market hours yesterday, 22 June 2017. Meanwhile, the S&P BSE Sensex was down 105.19 points, or 0.34% to 31,185.55. The S&P BSE Mid-Cap index was down 131.78 points, or 0.89% to 14,631.29. On the BSE, 2.85 lakh shares were traded in the counter so far, compared with average daily volumes of 2.53 lakh shares in the past one quarter. The stock had hit a high of Rs 577 and a low of Rs 559 so far during the day. The stock had hit a 52-week high of Rs 1,129 on 21 July 2016. The stock had hit a 52-week low of Rs 555 yesterday, 26 June 2017. The stock had dropped 12.18% in five sessions to settle at Rs 559.20 yesterday, 22 June 2017, from a close of Rs 636.80 on 15 June 2017. The stock had underperformed the market over the past one month till 22 June 2017, falling 12.76% compared with Sensex's 2.35% gains. The scrip had also underperformed the market in past one quarter, dropping 23.37% as against Sensex's 7.28% rise. The scrip had also underperformed the market in past one year, dropping 36.89% as against Sensex's 16.91% rise. The mid-cap company has equity capital of Rs 55.28 crore. Face value per share is Rs 5. Wockhardt said that the company and its two subsidiaries, Wockhardt UK Holdings and CP Pharmaceuticals (CP), have settled an ongoing commercial litigation before the High Court in London, UK in relation to a supply contract for a drug named Trisenox. The dispute between the parties was in respect of the price charged by CP to its counterparty to the contract, Cephalon Inc, (Cephalon) an affiliate of Teva Pharmaceuticals USA Inc. (Teva). The proceedings commenced in September 2015. Under the settlement between the parties, CP has agreed to waive its claim for the outstanding trade receivable of GBP 20 million and accordingly dropped its counterclaim for the said amount and further paid a sum of GBP 23 million to Teva and Cephalon by way of full and final settlement of Teva's claims. The high court has accepted the settlement between the parties and a consent order was issued on 21 June 2017. Pursuant to the settlement the ongoing litigation stands closed and all claims are dismissed. Wockhardt reported consolidated net loss of Rs 174.72 crore in Q4 March 2017, sharply higher than net loss of Rs 5.38 crore in Q4 March 2016. Wockhardt's consolidated net sales fell 14.5% to Rs 863.53 crore in Q4 March 2017 over Q4 March 2016. Wockhardt is a global pharmaceutical and biotech company with presence in USA, UK, Ireland, Mexico, Russia and many other countries.
|
| The announcement was made after market hours yesterday, 22 June 2017. Meanwhile, the S&P BSE Sensex was down 102.15 points or 0.33% at 31,188.59. On the BSE, 49.93 lakh shares were traded on the counter so far as against the average daily volumes of 38.03 lakh shares in the past one quarter. The stock had hit a high of Rs 204.60 and a low of Rs 190.15 so far during the day. The stock had hit a 52-week high of Rs 217.40 on 21 June 2017 and a 52-week low of Rs 57.05 on 22 November 2016. The stock had outperformed the market over the past one month till 22 June 2017, advancing 14.71% compared with the Sensex's 2.35% rise. The stock had also outperformed the market over the past one quarter, surging 137.08% as against the Sensex's 7.28% rise. The scrip had also outperformed the market over the past one year, advancing 105.02% as against the Sensex's 16.91% rise. The mid-cap company has equity capital of Rs 94.93 crore. Face value per share is Rs 2. On consolidated basis, Indiabulls Real Estate's net profit fell 3.7% to Rs 60.18 crore on 38.4% decline in net sales to Rs 437.03 crore in Q4 March 2017 over Q4 March 2016. Indiabulls Real Estate is a real estate development company with development projects spread across office and commercial complexes, premium residential developments, mega townships, retail spaces, hotel and resorts, special economic zones and infrastructure development.
|
Fortis Healthcare slumped 10.94% to Rs 176.30 after reports suggested IHH Healthcare Berhad is not close to concluding any negotiations to buy controlling stake in the company. The stock topped the losers in 'A' group. On the BSE, 21.43 lakh shares were traded on the counter so far as against the average daily volumes of 10.37 lakh shares in the past two weeks. With regards to news titled “HH Pulls Plug on Fortis Deal Over Daiichi Scare”, the company clarified during market hours today, 23 June 2017 that the company is still evaluating possible way to raise fund and no firm decision n the regard has been approve by the board till date. Videocon Industries was locked at 5% lower circuit at Rs 17.20. The stock was the second biggest loser in 'A' group. On the BSE, 4.97 lakh shares were traded on the counter so far as against the average daily volumes of 1.11 lakh shares in the past two weeks. The stock has been battered unabated after two lenders Central Bank of India and Dena Bank declared the company's account as non-performing assets (NPA). Hathway Cable & Datacom shed 4.5% at Rs 37.15. The stock was the third biggest loser in 'A' group. On the BSE, 40,000 shares were traded on the counter so far as against the average daily volumes of 69,000 shares in the past two weeks. Delta Corp dropped 4.44% at Rs 155. The stock was the fourth biggest loser in 'A' group. On the BSE, 6.42 lakh shares were traded on the counter so far as against the average daily volumes of 6.72 lakh shares in the past two weeks. Power Finance Corporation declined 4.35% at Rs 123. The stock was the fifth biggest loser in 'A' group. On the BSE, 4.51 lakh shares were traded on the counter so far as against the average daily volumes of 4.61 lakh shares in the past two weeks.
|
HealthCare Global Enterprises (HCG) clocked volume of 3.81 lakh shares by 13:46 IST on BSE, a 169.33-times surge over two-week average daily volume of 2,000 shares. The stock was up 1.38% at Rs 245.90. Tata Motors notched up volume of 8.39 crore shares, a 160.48-fold surge over two-week average daily volume of 5.23 lakh shares. The stock lost 1.72% at Rs 445. Max India saw volume of 1.41 crore shares, a 116.16-fold surge over two-week average daily volume of 1.22 lakh shares. The stock declined 1.51% at Rs 153.40. Himatsingka Seide clocked volume of 28.13 lakh shares, a 90.3-fold surge over two-week average daily volume of 31,000 shares. The stock advanced 4.65% at Rs 359. Merck saw volume of 85,000 shares, a 28.62-fold rise over two-week average daily volume of 3,000 shares. The stock lost 1.08% at Rs 1,089.
|
Meanwhile, the S&P BSE Sensex was down 129.47 points or 0.41% at 31,161.27. On the BSE, 2,999 shares were traded on the counter so far as against the average daily volumes of 6,393 shares in the past one quarter. The stock had hit a high of Rs 919.80 and a low of Rs 892 so far during the day. The stock had hit a record high of Rs 1,068 on 8 June 2017 and a record low of Rs 452.40 on 14 July 2016. The stock had outperformed the market over the past one month till 22 June 2017, advancing 8.37% compared with the Sensex's 2.35% rise. The stock had also outperformed the market over the past one quarter, gaining 28.57% as against the Sensex's 7.28% rise. The large-cap company has equity capital of Rs 126.79 crore. Face value per share is Rs 10. Quess Corp signed definitive agreements to acquire 46% equity in Heptagon Technologies on 21 June 2017. The transaction entails a cash consideration of Rs 9.77 crore. Separately, Quess Corp announced that on 21 June 2017 Quesscorp Holdings, a wholly owned subsidiary of the company has entered into definitive agreement to acquire 51% shareholding in Comtel Pro, a private limited company incorporated under the laws of Singapore. The announcement was made after market hours yesterday, 22 June 2017. On consolidated basis, Quess Corp's net profit remained almost same at Rs 27.64 crore in Q4 March 2017 compared to a year ago quarter. Net sales rose 12.6% to Rs 1122.09 crore in Q4 March 2017 over Q4 March 2016. Quess Corp is India's leading integrated business services provider. It serves customers across four segments namely, global technology solutions, people & services, integrated facility management and industrials.
|
Meanwhile, the S&P BSE Sensex was down 140.56 points, or 0.45%, to 31,150.18. The S&P BSE Mid-Cap index was down 219.34 points, or 1.49%, to 14,543.73. High volumes were witnessed on the counter. On the BSE, 16.34 lakh shares were traded in the counter so far, compared with an average volume of 9.7 lakh shares in the past one quarter. The stock had hit a high of Rs 187.60 and a low of Rs 174.45 so far during the day. The stock had hit a record high of Rs 230.90 on 3 May 2017. The stock had hit a 52-week low of Rs 142.60 on 9 November 2016. The stock had underperformed the market over the past one month till 22 June 2017, rising 1.59% compared with Sensex's 2.35% gains. The scrip had also outperformed the market in past one quarter, gaining 13.7% as against Sensex's 7.28% rise. The scrip had also outperformed the market in past one year, gaining 23.1% as against Sensex's 16.91% rise. The mid-cap company has an equity capital of Rs 518.46 crore. Face value per share is Rs 10. Earlier reports had suggested that IHH Healthcare Bhd will be buying a controlling stake in Fortis Healthcare and SRL Logistics from Malvinder and Shivinder Mohan Singh, the promoters of the company. The combined deal value of Fortis Healthcare and SRL Diagnostics was seen at around Rs 19000 crore and the deal was expected to complete within a few weeks. However, IHH Healthcare reportedly said IHH is not, nor is it close to, concluding any negotiations or due diligence or transactions in India at this point in time. IHH was wary of Daichhi Sankyo's ongoing Rs 3500 crore litigation against the Singh brothers and was not convinced that it would get clean and undisputed ownership of Fortis shares, report said. The Japanese company has disputed the right of the Singh brothers to sell their shares in their group companies until their arbitration dispute is settled. A Singapore arbitration tribunal has ordered the brothers to pay Rs 3500 crore to Daichhi Sankyo, who have challenged this order in the Delhi High Court. The arbitral award came after Daiichi alleged that the Singh brothers had concealed crucial information while selling Ranbaxy to it for $4.6 billion in 2008. The Singh brothers are contesting the award. Fortis Healthcare Holding has 52.2% stake in the firm as per the shareholding pattern as on 31 March 2017. The plan to sell their healthcare assets is part of the Singh brothers' strategy to divest control in all their key businesses through multiple transactions to raise funds to tide over the cash crunch at the group level. Fortis Healthcare reported consolidated net loss of Rs 37.52 crore in Q4 March 2017 compared with net loss of Rs 87.6 crore in Q4 March 2016. Net sales rose 5% to Rs 1123.43 crore in Q4 March 2017 over Q4 March 2016. Fortis Healthcare is a leading integrated healthcare delivery service provider in India. The healthcare verticals of the company primarily comprise hospitals, diagnostics and day care specialty facilities.
|
Meanwhile, the S&P BSE Sensex was down 126.65 points, or 0.4% at 31,164.09. The S&P BSE Small-Cap index was down 273.67 points, or 1.75% at 15,335.82. On the BSE, 14,000 shares were traded on the counter so far as against the average daily volumes of 15,969 shares in the past one quarter. The stock had hit a high of Rs 1,469.50 and a low of Rs 1,402.10 so far during the day. The stock had hit a 52-week high of Rs 1,498.70 on 22 June 2017 and a 52-week low of Rs 719.75 on 17 August 2016. The stock had outperformed the market over the past one month till 22 June 2017, advancing 35.6% compared with the Sensex's 2.35% rise. The scrip had also outperformed the market over the past one quarter gaining 73.04% as against the Sensex's 7.28% rise. The scrip had also outperformed the market over the past one year advancing 57.09% as against the Sensex's 16.91% rise. The small-cap company has equity capital of Rs 5.65 crore. Face value per share is Rs 10. Shares of Bharat Bijlee had rallied 22.8% in the preceding four trading sessions to settle at Rs 1,452.50 yesterday, 22 June 2017, from its close of Rs 1,182.85 on 16 June 2017. Bharat Bijlee's net profit spurted 317.5% to Rs 10.27 crore on 31.2% increase in net sales to Rs 222.12 crore in Q4 March 2017 over Q4 March 2016. Bharat Bijlee is one of the leading electrical engineering companies in India. The company's main business segments are transformers, projects, electric motors, elevator systems and drives & automation.
|
Meanwhile, the S&P BSE Sensex was down 126.47 points or 0.4% at 31,164.27. The S&P BSE Small-Cap index declined 277 points or 1.77% at 15,332.49. On the BSE, 42,000 shares were traded on the counter so far as against the average daily volumes of 58,634 shares in the past one quarter. The stock had hit a high of Rs 136 and a low of Rs 130.50 so far during the day. The stock had hit a 52-week high of Rs 150 on 13 February 2017 and a 52-week low of Rs 76.80 on 19 August 2016. The stock had outperformed the market over the past one month till 22 June 2017, advancing 10.03% compared with the Sensex's 2.35% rise. The stock had also outperformed the market over the past one quarter, gaining 12.53% as against the Sensex's 7.28% rise. The scrip had also outperformed the market over the past one year, advancing 32.61% as against the Sensex's 16.91% rise. The small-cap company has equity capital of Rs 97.68 crore. Face value per share is Rs 10. Shares of Prabhat Dairy had risen 10.35% in the preceding four trading sessions to settle at Rs 133.80 yesterday, 22 June 2017, from its closing of Rs 121.25 on 16 June 2017. On consolidated basis, Prabhat Dairy reported net loss of Rs 1.78 crore in Q4 March 2017, compared with net profit of Rs 5.84 crore in Q4 March 2016. Net sales rose 23% to Rs 377.18 crore in Q4 March 2017 over Q4 March 2016. Prabhat Dairy is an integrated milk and dairy products company. The company is engaged in the business of procurement and processing of milk and sale of milk and milk products, such as ghee, flavored milk, skimmed milk powder, whole milk powder and condensed milk.
|
| The announcement was made during market hours today, 23 June 2017. Meanwhile, the S&P BSE Sensex was down 68.07 points, or 0.22%, to 31,222.67. The S&P BSE Small-Cap index was down 238.54 points, or 1.53%, to 15,370.95. High volumes were witnessed on the counter. On the BSE, 41,667 shares were traded in the counter so far, compared with an average volume of 18,096 shares in the past one quarter. The stock was locked at a high of Rs 473.55. The stock had hit a low of Rs 456.20 so far during the day. The stock had hit a 52-week high of Rs 823 on 21 March 2017. The stock had hit a 52-week low of Rs 130.05 on 24 June 2016. The stock had underperformed the market over the past one month till 22 June 2017, rising 1.25% compared with Sensex's 2.35% gains. The scrip had also underperformed the market in past one quarter, dropping 41.69% as against Sensex's 7.28% rise. The scrip had, however, outperformed the market in past one year, jumping 228.6% as against Sensex's 16.91% rise. The small-cap company has equity capital of Rs 26.98 crore. Face value per share is Rs 10. Indian Metals & Ferro Alloys (IMFA) announced that the State Pollution Control Board has reinstated the 'consent to operate' for both of company's Sukinda and Mahagiri mines with immediate effect and valid as before until March 2021. On 11 April 2017, the company had said that following an inspection of Sukinda & Mahagiri mines on 22nd March 2017, the State Pollution Control Board had issued a notice pointing out certain non-compliances. Subsequently, the consent to operate (CTO) for both mines had been withdrawn. While mining operations had been stopped with effect from 11 April, there was no immediate impact on its ferro chrome operations. The company had said it was addressing all issues which have been pointed out and expect to revive the CTO in due course. Indian Metals & Ferro Alloys reported net profit of Rs 174 crore in Q4 March 2017 compared with net loss of Rs 37.29 crore in Q4 March 2016. The company's net sales spurted 188.5% to Rs 588.20 crore in Q4 March 2017 over Q4 March 2016. Established in 1961 in the Eastern State of Odisha known for its rich natural resources, IMFA is a fully integrated producer of ferro alloys.
|
Meanwhile, the S&P BSE Sensex was down 74.46 points or 0.24% at 31,216.28. The S&P BSE Mid-Cap index declined 197.39 points or 1.34% at 14,565.68. On the BSE, 6.37 lakh shares were traded on the counter so far as against the average daily volumes of 6.67 lakh shares in the past one quarter. The stock had hit a high of Rs 62.85 and a low of Rs 61 so far during the day. The stock had hit a 52-week high of Rs 72.85 on 1 August 2016 and a 52-week low of Rs 48.40 on 22 November 2016. The stock had underperformed the market over the past one month till 22 June 2017, sliding 5.51% compared with the Sensex's 2.35% rise. The stock had also underperformed the market over the past one quarter, gaining 2.21% as against the Sensex's 7.28% rise. The scrip had also underperformed the market over the past one year, sliding 4.99% as against the Sensex's 16.91% rise. The mid-cap company has equity capital of Rs 737.59 crore. Face value per share is Rs 10. Shares of Reliance Defence and Engineering have risen 7.65% in two trading sessions to its ruling price, from its closing of Rs 56.85 on 21 June 2017 after the company announced after market hours on 21 June 2017 that it has successfully delivered a bulk carrier to an international customer. The stock had risen 5.54% to settle at Rs 60 yesterday, 22 June 2017. Reliance Defence and Engineering successfully delivered a 73,500 dead weight tonne (DWT) new-built Ice-class Panamax Bulk Carrier to an international customer on 21 June 2017. Reliance Defence and Engineering reported net loss of Rs 139.92 crore in Q4 March 2017, compared with net profit of Rs 102.44 crore in Q4 March 2016. Net sales rose 140.6% to Rs 227.89 crore in Q4 March 2017 over Q4 March 2016. Reliance Defence and Engineering (RDEL) has a large ship building/repair infrastructure in India. It has one of the largest dry docks in the world.
|
| The announcement was made during market hours today, 23 June 2017. Meanwhile, the S&P BSE Sensex was down 53.84 points, or 0.17% at 31,236.90. The S&P BSE Small-Cap index was down 195.05 points or 1.25% at 15,414.44. On the BSE, 4,943 shares were traded on the counter so far as against the average daily volumes of 1.77 lakh shares in the past one quarter. The stock had hit a high of Rs 285 and a low of Rs 280.05 so far during the day. The stock had hit a record high of Rs 343.70 on 30 March 2017 and a 52-week low of Rs 162.05 on 24 June 2016. The stock had dropped 8.68% in four sessions to Rs 278.15 yesterday, 22 June 2017 from a close of Rs 304.60 on 16 June 2017. The stock had underperformed the market over the past one month till 22 June 2017, falling 9.07% compared with Sensex's 2.35% gains. The scrip had also underperformed the market in past one quarter, dropping 15.08% as against Sensex's 7.28% rise. The scrip had, however, outperformed the market in past one year, gaining 58.76% as against Sensex's 16.91% rise. The small-cap company has equity capital of Rs 32 crore. Face value per share is Rs 10. Deep Industries said that the contract is for securing the services of 30 tons workover rig to be deployed in ONGC coal bed methane (CBM) asset, Bokaro. The tenure of the contract is one year and the total estimated value of the contract is Rs 3.72 crore. Deep Industries' net profit spurted 81.2% to Rs 23.23 crore on 36.5% increase in net sales to Rs 74.90 crore in Q4 March 2017 over Q4 March 2016. Deep Industries is engaged in business of oil and gas services, exploration and production.
|
Meanwhile, the S&P BSE Sensex was down 57.88 points, or 0.18% at 31,232.86. The S&P BSE Small-Cap index was down 194.63 points, or 1.25% at 15,414.86. On the BSE, 1,627 shares were traded on the counter so far as against the average daily volumes of 9,106 shares in the past one quarter. The stock had hit a high of Rs 1,430 and a low of Rs 1,375.60 so far during the day. The stock had hit a 52-week high of Rs 2,355 on 1 July 2016 and a 52-week low of Rs 1,122 on 7 June 2017. The stock had underperformed the market over the past one month till 22 June 2017, declining 10.88% compared with the Sensex's 2.35% rise. The scrip had also underperformed the market over the past one quarter declining 16.25% as against the Sensex's 7.28% rise. The scrip had also underperformed the market over the past one year declining 34.59% as against the Sensex's 16.91% rise. The small-cap company has equity capital of Rs 10 crore. Face value per share is Rs 10. Shares of DFM Foods had rallied 17.87% in the preceding five trading sessions to settle at Rs 1,416.90 yesterday, 22 June 2017, from its close of Rs 1,202.15 on 15 June 2017. ABG Capital sold 52,000 shares of the company at Rs 1,400.58 per share in a bulk deal on the BSE yesterday, 22 June 2017. ABG Capital sold 75,282 shares of the company at Rs 1,401.08 per share in a bulk deal on the NSE yesterday, 22 June 2017. ABG Capital held 1.57% stake in DFM Foods end March 2017. LTR Focus Fund sold 1.24 lakh shares of the company at Rs 1,400.15 per share in a bulk deal on the BSE yesterday, 22 June 2017. LTR Focus Fund held 1.52% stake in DFM Foods end March 2017. Steadview Capital Mauritius sold 1.27 lakh shares of the company at Rs 1,400.15 per share in a bulk deal on the BSE yesterday, 22 June 2017. Steadview Capital Mauritius sold 1.18 lakh shares of the company at Rs 1,404.74 per share in a bulk deal on the NSE yesterday, 22 June 2017. Steadview Capital Mauritius held 3.05% stake in DFM Foods end March 2017. DFM Foods' net profit fell 68.5% to Rs 3.66 crore on 24.2% decrease in net sales to Rs 93.17 crore in Q4 March 2017 over Q4 March 2016. DFM Foods is engaged in manufacturing and marketing of snack foods.
|
Meanwhile, the S&P BSE Sensex was down 63.68 points or 0.2% at 31,227.06. The S&P BSE Small-Cap index declined 209.74 points or 1.34% at 15,399.75. On the BSE, 87,000 shares were traded on the counter so far as against the average daily volumes of 67,279 shares in the past one quarter. The stock had hit a high of Rs 160.80 so far during the day, which is also its record high. The stock hit a low of Rs 150.70 so far during the day. The stock had hit a 52-week low of Rs 70.10 on 30 September 2016. The stock had outperformed the market over the past one month till 22 June 2017, advancing 40.32% compared with the Sensex's 2.35% rise. The stock had also outperformed the market over the past one quarter, gaining 41.4% as against the Sensex's 7.28% rise. The scrip had also outperformed the market over the past one year, advancing 108.31% as against the Sensex's 16.91% rise. The small-cap company has equity capital of Rs 39.08 crore. Face value per share is Rs 2. Shares of Graphite India had surged 32.31% in the preceding eight trading sessions to settle at Rs 155.40 yesterday, 22 June 2017, from its close of Rs 117.45 on 12 June 2017. Graphite India's net profit spurted 117% to Rs 61.97 crore on 7.2% increase in net sales to Rs 366.22 crore in Q4 March 2017 over Q4 March 2016. Graphite India is engaged in the manufacture of graphite electrodes including carbon and graphite specialty products.
|
|
|